This site uses cookies. By using this site you agree to receiving cookies. View Policy.
Celixir (previously trading as Cell Therapy) is a British pioneer in Regenerative Medicine. Its team of scientists and biotechnology leadership is devoted to discovering breakthrough medicines that aim to change the standard of medical care for patients.
More financial returns for Crowdcube investors as biotech company Celixir delivers 2.7x return with share buy-back Angel News Newsletter |
12/04/2017 |
Crowdcube Success Cell Therapy Receives £12.5M in Japan Rights Deal Crowdfund Insider |
10/05/2016 |
Crowdcube Success Cell Therapy Receives £12.5M in Japan Rights Deal Crowdfund Insider |
10/05/2016 |
Cell Therapy eyes initial public offering Media Wix |
04/10/2015 |
06970743
23/07/2009
Active
Other research and experimental development on natural sciences and engineering
1
Date | Amount | No. of Investors | |
---|---|---|---|
01/12/2014 | £689,246 | 297 | View |
2018 | 2019 | |
---|---|---|
Turnover | £715.38k | £765.11k |
Cash | £5.23m | £1.79m |
Increase in Cash | - | - |
Financial data drawn from last filed accounts don't necessarily reflect current trading activity.
Name | Role | Appointed | Nationality |
---|---|---|---|
CELIXIR PLC | Corporate-director | 19/01/2019 |